Search

everythinglearnresearchcommunity

for

Search:↓

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Older patients sticking to their prostate medication saw lasting health benefits.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

More people are seeing dermatologists for hair and scalp problems now than in the past.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Mesotherapy seems safe and effective for hair loss, but more research is needed.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Finasteride may worsen blood sugar control in diabetic patients.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

The document concludes that more research is needed on treatments for hair loss in both men and women, especially on medication combinations and their benefits.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

5ARI treatment improves hair growth in older men with minimal side effects.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.